Peripartum Pharmacotherapy: A Pharmacist's Guide

Kylie N. Barnes, Lauren D. Leader,Nicole E. Cieri-Hutcherson, Julie Kelsey,Mary F. Hebert,Lamis R. Karaoui, Sarah McBane

JOURNAL OF PHARMACY PRACTICE(2024)

引用 2|浏览1
暂无评分
摘要
Complications throughout the peripartum period may be caused by preexisting conditions or pregnancy-induced conditions and may alter pharmacotherapy management. Pharmacotherapy management during late pregnancy and delivery requires careful consideration due to changing hormones, hemodynamic status, and pharmacokinetics, and concerns for potential maternal and/or fetal morbidity. Increased maternal and fetal monitoring are often required and may lead to therapy changes. Pharmacists, as key members of the interprofessional team, can contribute essential perspective to the management of postpartum pharmacotherapy through assessment and recommendation of appropriate and judicious use of medications.
更多
查看译文
关键词
peripartum,intrapartum,postpartum,labor and delivery
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要